Teleflex (NYSE:TFX) Reaches New 1-Year Low - Time to Sell?

Teleflex Incorporated (NYSE:TFX - Get Free Report)'s stock price reached a new 52-week low on Monday . The stock traded as low as $179.26 and last traded at $180.30, with a volume of 10980 shares changing hands. The stock had previously closed at $180.14.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. StockNews.com upgraded Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Mizuho lowered their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. Royal Bank of Canada dropped their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Truist Financial reissued a "hold" rating and issued a $227.00 price objective (down from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Monday. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $259.00.

Teleflex Stock Performance

The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $8.23 billion, a PE ratio of 35.24, a PEG ratio of 1.84 and a beta of 1.16. The firm's 50-day simple moving average is $207.16 and its 200-day simple moving average is $220.52.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. The firm had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex's quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.64 earnings per share. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.77%. Teleflex's dividend payout ratio is currently 27.04%.

Institutional Investors Weigh In On Teleflex

Several large investors have recently modified their holdings of TFX. Janus Henderson Group PLC raised its position in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock worth $1,329,704,000 after acquiring an additional 147,147 shares in the last quarter. State Street Corp raised its holdings in Teleflex by 1.0% in the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock worth $508,757,000 after purchasing an additional 21,291 shares in the last quarter. Geode Capital Management LLC raised its holdings in Teleflex by 0.5% in the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock worth $278,676,000 after purchasing an additional 5,746 shares in the last quarter. Cooke & Bieler LP lifted its position in shares of Teleflex by 23.3% during the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company's stock valued at $191,989,000 after buying an additional 172,335 shares during the last quarter. Finally, TD Asset Management Inc boosted its holdings in shares of Teleflex by 12.0% in the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company's stock valued at $95,928,000 after buying an additional 48,832 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.